Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 6Hodgkin Disease 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, T-Cell 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Gliosarcoma 3Glioblastoma 3Burkitt Lymphoma 3Multiple Myeloma 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Prolymphocytic, T-Cell 2Glioma 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

fludarabine phosphate 23Peripheral Blood Stem Cell Transplantation 19Whole-Body Irradiation 18Mycophenolic Acid 16Cyclophosphamide 15Busulfan 15Tacrolimus 14Antilymphocyte Serum 14Cyclosporine 11Melphalan 10Rituximab 9Methotrexate 9Etoposide 8romidepsin 6Flow Cytometry 6Filgrastim 6Vorinostat 5Dexamethasone 5thymoglobulin 4fludarabine 4Sirolimus 4Granulocyte Colony-Stimulating Factor 4Carboplatin 4Calcium Dobesilate 4Bexarotene 4Alemtuzumab 4Thiotepa 3Therapeutics 3Radiotherapy 3Panobinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, T-Cell, Cutaneous × carmustine, poliferprosan 20 drug combination × Clear all
NCT00961220 2018-05-22

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 1/2 Completed
17 enrolled 6 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡